Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.

Luftig M, Prinarakis E, Yasui T, Tsichritzis T, Cahir-McFarland E, Inoue J, Nakano H, Mak TW, Yeh WC, Li X, Akira S, Suzuki N, Suzuki S, Mosialos G, Kieff E.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15595-600. Epub 2003 Dec 12.

2.

Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.

Luftig M, Yasui T, Soni V, Kang MS, Jacobson N, Cahir-McFarland E, Seed B, Kieff E.

Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):141-6. Epub 2003 Dec 22.

3.

IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.

Song YJ, Jen KY, Soni V, Kieff E, Cahir-McFarland E.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2689-94. Epub 2006 Feb 13.

4.

Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.

Song YJ, Kang MS.

Virus Genes. 2010 Oct;41(2):174-80. doi: 10.1007/s11262-010-0505-4. Epub 2010 Jun 29.

PMID:
20585848
5.
6.

Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-κB activation.

Kim JE, Kim SY, Lim SY, Kieff E, Song YJ.

Mol Cell Biol. 2014 Feb;34(3):325-34. doi: 10.1128/MCB.00912-13. Epub 2013 Nov 18.

7.
9.

Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.

Sylla BS, Hung SC, Davidson DM, Hatzivassiliou E, Malinin NL, Wallach D, Gilmore TD, Kieff E, Mosialos G.

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10106-11.

10.
11.

TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB.

Uemura N, Kajino T, Sanjo H, Sato S, Akira S, Matsumoto K, Ninomiya-Tsuji J.

J Biol Chem. 2006 Mar 24;281(12):7863-72. Epub 2006 Jan 30.

13.

The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.

Shkoda A, Town JA, Griese J, Romio M, Sarioglu H, Knöfel T, Giehler F, Kieser A.

PLoS Biol. 2012;10(8):e1001376. doi: 10.1371/journal.pbio.1001376. Epub 2012 Aug 14.

14.

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.

Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G.

Mol Cell Biol. 1996 Dec;16(12):7098-108.

15.

LMP1 TRAFficking activates growth and survival pathways.

Soni V, Cahir-McFarland E, Kieff E.

Adv Exp Med Biol. 2007;597:173-87. Review.

PMID:
17633026
17.

Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases.

Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham ET Jr, Grant M, Connelly MA, Hambor JE, Marcu KB, Greene WC.

Mol Cell Biol. 1998 Sep;18(9):5157-65.

18.

TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1.

Schultheiss U, Püschner S, Kremmer E, Mak TW, Engelmann H, Hammerschmidt W, Kieser A.

EMBO J. 2001 Oct 15;20(20):5678-91.

19.

Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.

Devergne O, Cahir McFarland ED, Mosialos G, Izumi KM, Ware CF, Kieff E.

J Virol. 1998 Oct;72(10):7900-8.

20.

Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

Saito S, Murata T, Kanda T, Isomura H, Narita Y, Sugimoto A, Kawashima D, Tsurumi T.

J Virol. 2013 Apr;87(7):4060-70. doi: 10.1128/JVI.02020-12. Epub 2013 Jan 30.

Supplemental Content

Support Center